Apoptosis is instrumental in the processes generating the diversity of the
B-cell repertoire. Autoreactive B-cells are eliminated by anti-IgM crosslin
king after encountering self-antigens, but precise mechanisms leading to B-
cell apoptosis are still not well understood. We report here the cleavage o
f the transcription factor SP1 in the human Burkitt lymphoma cell Line BL60
during anti-IgM-induced apoptosis. Western blot analysis revealed two clea
vage products of approximately 68 kDa and 45 kDa after induction of apoptos
is. Cleavage could be completely inhibited by zDEVD-fmk, an inhibitor speci
fic for caspase 3-like proteases. In-vitro cleavage of recombinant SP1 by r
ecombinant caspase 3 (CPP32) or caspase 7 (Mch 3) results in similar cleava
ge products as those observed in vivo. Recombinant caspase 6 (Mch 2) primar
ily generates a 68-kDa cleavage product, as observed after calcium ionophor
e (CaI) induced B-cell apoptosis. In contrast, caspase 1 (ICE) did not clea
ve SP1 in vitro. The time course of SP1 cleavage during anti-IgM-induced ap
optosis is paralleled by an increase of caspase activity measured by DEVD-p
-nitroanilide (DEVD-pNA) cleavage. DNA band-shift assays revealed a decreas
e in the intensity of the full length SP1/DNA complex and an increase in th
e intensity of a smaller complex due to the binding of one SP1 cleavage pro
duct. By Edman sequencing we could identify a caspase 3 cleavage site after
Asp584 (D(584)AQPQAGR), generating a 22-kDa C-terminal SP1 protein fragmen
t which still contains the DNA binding site. Our results show the cleavage
of the human transcription factor SP1 in vivo and in vitro, underlining the
central role of caspase 3-like proteases during the process of anti-IgM-in
duced apoptosis.